Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 1/2 Open-Label, Multicenter, Global Trial to Characterize the Safety, Tolerability and Preliminary Efficacy of CFT1946 as a Monotherapy and in Combination with Trametinib in Subjects with BRAF
Sponsored by C4 Therapeutics, Inc.
Active
$433.9K Funding
3 People
External
Related Topics
drug development,
oncology,
clinical trials,
pharmacology,
precision medicine
People
Octavio Castanos
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
Clara Curiel
Co-Investigator (COI)
Medicine
﹒Professor
